Skip to content

Public FDA record

Z-2356-2020: BD FACS Sample Prep Assistant (SPA) II - Product Usage: K050191: The BD FACSCanto system with BD FACSCant

Recall record Z-2356-2020 for Becton, Dickinson and Company, BD Biosciences. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2356-2020
Company in FDA record
Becton, Dickinson and Company, BD Biosciences
FDA record creation date
Jun 11, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The recalling firm confirmed that BD FACS Sample Prep Assistant (SPA) II and III users may encounter probes with unacceptable wear prior to reaching the 2500 piercings guideline indicated in the Instructions for Use (IFU). When the probe is worn, particles from the rubber cap are more likely to clog the probe, resulting in blocked or inadequate sample dispense.

Source facts

Action
The recall was initiated by customer letter dated July 8th, 2019 via UPS/FEDEX and email. The following actions are to be taken: Follow the FACS Sample Prep Assistant II or III System Instructions for Use (IFU) directions for inspecting the probe daily for wear as part of the daily startup procedure. For both SPA II and III IFUs, this may be found in Chapter 5. Instructions for replacing the probe can be located in the Shutdown and Maintenance chapter of the IFU. For SPA II this may be found in Chapter 7. For SPA III this may be found in Chapter 6. The following provides additional detail regarding the probe inspection process: 1. Visually check the probe for signs of wear (the probe is no longer straight or the Teflon coating is gone). Note: the probe does not need to be removed from the system for this inspection. 2. Replace and discard the probe in accordance with the IFU if the probe shows signs of unacceptable wear. Report any adverse health consequences experienced with the use of this product . Events may also be reported to the FDA's MedWatch Adverse Event Reporting program. Web: MedWatch website at www.fda.gov/medwatch, Phone: 1-800-FDA-1088 (1-800-332-1088). For further assistance, contact Customer Support at 855236-2772 (prompt 2), and for customers outside the US , contact the local representative or distributor.
Initiated
2019-07-08
Root cause
Component design/selection
Terminated
2023-01-31
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, CO,CT, GA, IL, MA, MI, MD, NC, NH,NJ, NY, OH, PA, TN, TX, VA, and VT. The countries of Australia, Botswana, Brazil, Canada, Chile, China, Colombia, Costa Rica, Europe, Hong Kong, India, Italy, Jamaica, Japan, Kazakhstan, Malaysia, Martinique, Mexico, New Zealand, Nicaragua, Peru, Puerto Rico (US), Romania, Russia, Singapore, South Africa, South Korea, Swaziland, Switzerland, Turkey, US, Vietnam.
Recall number
Z-2356-2020
Recall status
Terminated
CDRH record ID
180157
FDA record created
2020-06-11
Recall event number
85129

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗